1. Home
  2. VABK vs DTIL Comparison

VABK vs DTIL Comparison

Compare VABK & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$43.40

Market Cap

231.3M

Sector

Finance

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$6.86

Market Cap

185.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
DTIL
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.3M
185.3M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
VABK
DTIL
Price
$43.40
$6.86
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$45.00
AVG Volume (30 Days)
2.9K
323.4K
Earning Date
04-23-2026
05-14-2026
Dividend Yield
3.39%
N/A
EPS Growth
12.70
N/A
EPS
0.97
N/A
Revenue
N/A
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$43.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.48
$3.53
52 Week High
$48.58
$8.82

Technical Indicators

Market Signals
Indicator
VABK
DTIL
Relative Strength Index (RSI) 59.80 50.21
Support Level $37.99 $6.58
Resistance Level $48.58 $8.12
Average True Range (ATR) 0.75 0.61
MACD -0.00 -0.06
Stochastic Oscillator 100.00 45.05

Price Performance

Historical Comparison
VABK
DTIL

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: